MedPath

IBUPROFEN AND FAMOTIDINE

These highlights do not include all the information needed to use IBUPROFEN and FAMOTIDINE TABLETS safely and effectively. See full prescribing information for IBUPROFEN and FAMOTIDINE TABLETS. IBUPROFEN and FAMOTIDINE tablets, for oral use Initial U.S. Approval: 2011

Approved
Approval ID

03733e49-7db4-4d98-b363-d0d23686ec72

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Mar 15, 2023

Manufacturers
FDA

Ascent Pharmaceuticals, Inc.

DUNS: 080938961

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Ibuprofen and famotidine

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code43602-544
Application NumberANDA216814
Product Classification
M
Marketing Category
C73584
G
Generic Name
Ibuprofen and famotidine
Product Specifications
Route of AdministrationORAL
Effective DateMay 27, 2022
FDA Product Classification

INGREDIENTS (13)

IBUPROFENActive
Quantity: 800 mg in 1 1
Code: WK2XYI10QM
Classification: ACTIB
FAMOTIDINEActive
Quantity: 26.6 mg in 1 1
Code: 5QZO15J2Z8
Classification: ACTIB
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61U
Classification: IACT
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
HYDROXYPROPYL CELLULOSE, UNSPECIFIEDInactive
Code: 9XZ8H6N6OH
Classification: IACT
GLYCERINInactive
Code: PDC6A3C0OX
Classification: IACT
POVIDONEInactive
Code: FZ989GH94E
Classification: IACT
FD&C BLUE NO. 1Inactive
Code: H3R47K3TBD
Classification: IACT
FD&C BLUE NO. 2Inactive
Code: L06K8R7DQK
Classification: IACT
TALCInactive
Code: 7SEV7J4R1U
Classification: IACT
CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.